U.S. Markets open in 2 hrs 39 mins

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
65.82-1.04 (-1.56%)
At close: 4:00PM EDT
People also watch
BLUEKITECLVSJUNOEPZM
Full screen
Previous Close66.86
Open67.15
Bid0.00 x 0
Ask71.00 x 300
Day's Range65.75 - 67.72
52 Week Range39.24 - 67.74
Volume322,503
Avg. Volume513,895
Market Cap3.19B
Beta2.06
PE Ratio (TTM)-10.40
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETFs with exposure to Agios Pharmaceuticals, Inc. : September 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Agios Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to AGIO-US. Comparing the performance and risk of Agios Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Agios Pharmaceuticals Inc.
    Markit8 days ago

    See what the IHS Markit Score report has to say about Agios Pharmaceuticals Inc.

    Short interest is moderately high for AGIO with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.

  • Market Realist13 days ago

    Jazz Pharmaceuticals on the Street: Analysts’ Recommendations after 1H17

    In July 2017, Jazz Pharmaceuticals entered into a license agreement with XL-Protein GmbH involving products using XL-Protein’s PASylation technology.